Credit Suisse analyst Kennen MacKay reiterated a Buy rating on Clovis Oncology (NASDAQ: CLVS) today and set a price target
Category: Healthcare
Cantor Fitzgerald Thinks Egalet Corp’s Stock is Going to Recover
Cantor Fitzgerald analyst Chiara Russo reiterated a Buy rating on Egalet Corp (NASDAQ: EGLT) today and set a price target
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (NASDAQ: CRBP), GlycoMimetics (NASDAQ: GLYC) and vTv Therapeutics (NASDAQ: VTVT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Corbus Pharmaceuticals
Akorn was Downgraded to a Sell Rating at Merrill Lynch
Akorn (NASDAQ: AKRX) received a Sell rating and a $22 price target from Merrill Lynch analyst Sumant Kulkarni today. The
Roth Capital Reiterates a Buy Rating on NeoGenomics
In a report released today, Chris Lewis from Roth Capital reiterated a Buy rating on NeoGenomics (NASDAQ: NEO), with a
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Horizon Pharma Inc. (NASDAQ: HZNP) and Tearlab Corp. (NASDAQ: TEAR)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Horizon Pharma Inc. (NASDAQ: HZNP)
Nektar Therapeutics Receives a Buy from Roth Capital
Roth Capital analyst Michael Higgins reiterated a Buy rating on Nektar Therapeutics (NASDAQ: NKTR) on November 4 and set a